UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 17, 2003
Global Life Sciences, Inc.
------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Nevada
--------------------
(State or other jurisdiction of incorporation)
000-33333 37-9374101
------------------- -------------------
(Commission File Number) (I.R.S. Employer Identification No.)
2020 Main Street, Suite 600, Irvine, California 92614
------------------------------------------------- --------
(Address of Principal Executive Offices) (Zip Code)
949-223-7103
----------------------
(Registrant's Telephone Number, including area code)
Too Gourmet, Inc.
--------------------------
(Former Name or Former Address, if Changed Since Last Report)
- 1 -
Item 1. Changes in Control of Registrant.
Pursuant to an Asset Purchase and Sale Agreement (the
"Acquisition Agreement"), with an effective date of
September 22, 2003, by and among Prof. Dr. Dr. Hans-Jurgen
Reimann ("Prof. Reimann") and Dr. Antje Reimann ("Dr.
Reimann") and Too Gourmet, Inc., a Nevada corporation (the
"Registrant"), and Global Life Sciences, Inc., a Nevada
corporation formed as its wholly-owned subsidiary, the
Registrant acquired (the "Transaction") the medical business
assets and related intellectual property of a medical
laboratory and service provider, doing business as the
Internationale Fachklinik ("lab") located in Schwerin,
Germany (the "Acquired Assets and Business") from Prof.
Reimann and Dr. Reimann (the "Transaction"). The
Transaction was reported on Form 8-K filed with the
Securities and Exchange Commission (the "Commission") on
November 5, 2003.
In connection with the Transaction, the Registrant
effected a merger of Global Life Sciences, Inc. with and
into Too Gourmet, Inc., the Registrant and the surviving
entity. The Registrant's name was changed to "Global Life
Sciences, Inc." and a new trading symbol ("GBLS") and Cusip
number were assigned to the Registrant. Such name change,
new trading symbol and new Cusip number were disclosed in
Form 8-K filed with the Commission on November 18, 2003.
The Registrant filed its Articles of Merger with the
Nevada Secretary of State on November 12, 2003, and its
Certificate of Correction with the Nevada Secretary of State
on November 17, 2003. Copies of the filed Articles of
Merger and Certificate of Correction are attached to this
Form 8-K.
Item 7. Financial Statements and Exhibits
a. Financial Statements
None.
b. Pro forma Financial Information
None.
c. Exhibits.
3.3 Articles of Merger
3.4 Certificate of Correction
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly
authorized.
GLOBAL LIFE SCIENCES, INC.
November 19, 2003 By: /s/ Harrysen Mittler
-----------------------
Harrysen Mittler
Chief Financial Officer
- 3 -
Exhibit Index.
3.3 Articles of Merger
3.4 Certificate of Correction